AI in Genomics Market Overview, Key Trends, and Insights on Leading Companies

The AI in genomics industry is set to experience remarkable growth, driven by technological advances and increasing integration of artificial intelligence in healthcare and research. As precision medicine continues to gain traction, the market is poised to expand significantly in the upcoming years, transforming how genomic data is analyzed and applied.

Projected Market Value of the AI in Genomics Market by 2030
The AI in genomics market is anticipated to grow dramatically, reaching a value of $9.32 billion by 2030. This expansion corresponds to an impressive compound annual growth rate (CAGR) of 43.7%. Factors propelling this growth include the rising adoption of precision medicine techniques, increased funding in AI-driven drug discovery, the broadening scope of population genomics initiatives, and a growing preference for personalized healthcare solutions. Moreover, advancements in deep learning models tailored for genomic data analysis are playing a significant role. Key trends expected to shape the market include wider acceptance of AI-powered genome analysis tools, enhanced use of machine learning for detecting genetic variants, integration of AI in gene editing protocols, expansion of cloud-enabled genomic data processing, and a heightened focus on accurate pattern recognition.

Download a free sample of the ai in genomics market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9612&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=May_PR

Emerging Players in the AI in Genomics Market
Several prominent companies are actively shaping the AI in genomics landscape. These include International Business Machines Corporation, Microsoft Corp., NVIDIA Corporation, Deep Genomics Inc., BenevolentAI Ltd., Fabric Genomics Inc., Verge Genomic Inc., Freenome Holdings Inc., MolecularMatch Inc., SOPHiA GENETICS SA, Data4Cure Inc., PrecisionLife Ltd., Genoox Ltd., Lifebit Ltd., Empiric Logic Ltd., FDNA Inc., DNAnexus Inc., Engine Biosciences Pte Ltd., 4baseCare, Congenica Ltd., CytoReason Ltd., Emedgene Technologies LTD, Illumina Inc., Mendel.ai, Predictive Oncology Inc., Tempus Labs Inc., 10x Genomics Inc., Repositive Limited, Genedata AG, Global Gene Corp, Nference Inc., Bluebee Holding B.V., and Genomenon Inc.
In a notable development in September 2025, SeqOne S.A.S., a healthcare technology company based in France, acquired the UK-based Congenica for an undisclosed amount. This acquisition is intended to strengthen SeqOne's position as a global leader in AI-driven genomic medicine by combining advanced AI analytics with Congenica's trusted clinical interpretation services.

Current Trends Steering the AI in Genomics Market
Leading firms in the AI in genomics sector are prioritizing the development of innovative solutions such as drug discovery platforms that leverage computational tools, AI algorithms, and laboratory automation to efficiently identify and optimize new drug candidates. One example is Genomic Vision, a biotechnology company headquartered in France that specializes in diagnostic tools for genetic disorders and cancers. In March 2023, they launched FiberSmart, an AI-powered software designed to visualize and analyze long DNA fibers at high resolution. This cutting-edge technology holds the potential to revolutionize diagnosis and treatment of genetic diseases by enhancing precision and efficiency. By processing vast datasets, FiberSmart can detect patterns and insights that are beyond human capability.

View the full ai in genomics market report:
https://www.thebusinessresearchcompany.com/report/ai-in-genomics-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=May_PR

Breakdown of Market Segments in the AI in Genomics Industry
The AI in genomics market is segmented in several key ways:
1) By Component: Hardware, Software, Services
2) By Technology: Machine Learning, Computer Vision
3) By Functionality: Genome Sequencing, Gene Editing, Other Functionalities
4) By Application: Drug Discovery and Development, Precision Medicine, Diagnostics, Other Applications
5) By End-Use: Pharmaceutical and Biotech Companies, Healthcare Providers, Research Centers, Other End-Users
Further subcategories include:
- Hardware: Servers, Storage Devices, Networking Equipment
- Software: Data Analysis Software, Machine Learning Algorithms, Visualization Tools, Genomic Data Management Software
- Services: Consulting Services, Integration Services, Support and Maintenance, Data Analytics Services

This detailed segmentation allows for a comprehensive understanding of the AI in genomics market, highlighting its technological diversity and broad applicability across healthcare and research sectors.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.